» Articles » PMID: 39731510

Correlation Between Ultrasonography and Elastography Parameters and Molecular Subtypes of Breast Cancer in Young Women

Overview
Journal Ann Med
Publisher Informa Healthcare
Specialty General Medicine
Date 2024 Dec 28
PMID 39731510
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To explore the differences of conventional ultrasound characteristics, elastic imaging parameters and clinicopathological characteristics of distinct molecular subtypes of breast cancer in young women, and to identify imaging parameters that exhibited significant associations with each molecular subtype.

Methods: We performed a retrospective analysis encompassing 310 young women with breast cancer. Observations were made regarding the ultrasonography and elastography characteristics of the identified breast lesions. Subsequently, based on immunohistochemistry results patients were classified into five distinct molecular subtypes: luminal A, luminal B (HER2-), luminal B (HER2+), HER2+, and triple-negative breast cancer (TNBC). Clinical, pathological, and ultrasound imaging features were compared among these subtypes using binary logistic regression analysis.

Results: Statistically significant differences were observed in various parameters across the five molecular subtypes ( < 0.05), including tumor size, morphology, margins, calcification, posterior echo features, blood flow (Adler grading), and tumor hardness. Specifically, luminal A subtype exhibited propensity for spiculated margins, lower blood flow grading, and decreased hardness; luminal B subtype was characterized by angular margins; HER2+ subtype manifested higher blood flow grading, calcification, and elevated hardness. Conversely, TNBC subtype displayed smooth margins, absence of calcification, and heightened hardness.

Conclusion: Specific molecular subtypes of breast cancer have unique ultrasonic and elastic imaging characteristics.

References
1.
Irshad A, Leddy R, Pisano E, Baker N, Lewis M, Ackerman S . Assessing the role of ultrasound in predicting the biological behavior of breast cancer. AJR Am J Roentgenol. 2013; 200(2):284-90. DOI: 10.2214/AJR.12.8781. View

2.
Paluch-Shimon S, Cardoso F, Partridge A, Abulkhair O, Azim H, Bianchi-Micheli G . ESO-ESMO fifth international consensus guidelines for breast cancer in young women (BCY5). Ann Oncol. 2022; 33(11):1097-1118. DOI: 10.1016/j.annonc.2022.07.007. View

3.
Evans A, Trimboli R, Athanasiou A, Balleyguier C, Baltzer P, Bick U . Breast ultrasound: recommendations for information to women and referring physicians by the European Society of Breast Imaging. Insights Imaging. 2018; 9(4):449-461. PMC: 6108964. DOI: 10.1007/s13244-018-0636-z. View

4.
Swain S, Nunes R, Yoshizawa C, Rothney M, Sing A . Quantitative Gene Expression by Recurrence Score in ER-Positive Breast Cancer, by Age. Adv Ther. 2015; 32(12):1222-36. PMC: 4679789. DOI: 10.1007/s12325-015-0268-3. View

5.
Ian T, Tan E, Chotai N . Role of mammogram and ultrasound imaging in predicting breast cancer subtypes in screening and symptomatic patients. World J Clin Oncol. 2021; 12(9):808-822. PMC: 8479344. DOI: 10.5306/wjco.v12.i9.808. View